Hoag is proud to offer CyberKnife® as a technologically advanced treatment option in the fight against cancer.
Hoag is collaborating with Newport Diagnostic Center (NDC) to offer this minimally-invasive treatment option as part of Hoag’s comprehensive, personalized and integrated approach to cancer treatment. The CyberKnife® offers a renewed sense of hope to patients who may not be surgical candidates, while often providing an excellent adjunct therapy for those patients undergoing cancer surgery.
The CyberKnife is an FDA-cleared, non-invasive, robotic radiosurgery system that treats both cancerous and non-cancerous tumors with sub-millimeter accuracy. In the care of Hoag-affiliated Radiation Oncologist Amanda Schwer, M.D., patients are treated in single or fractioned doses (typically in 1-5 sessions) by delivering multiple beams of precisely directed radiation that converge upon the tumor, minimizing damage to surrounding healthy tissue. With the unique ability to provide sub-millimeter precision and thereby spare healthy tissue, the CyberKnife is often capable of safely delivering curative doses in cases which were previously considered untreatable. The CyberKnife is capable of treating tumors and lesions located in the brain, spine, prostate, lung, liver and pancreas; virtually anywhere in the body.
Should your patient be faced with a cancer diagnosis, you can be assured that Hoag will deliver the best treatment option for each specific patient. Hoag also offers other minimally-invasive alternatives to surgical cancerous tumor removal including Gamma Knife PerfexionÒ. Hoag has one of the only Gamma Knife PerfexionsÒ in Southern California and is the only provider in Orange County offering both the CyberKnife and the Gamma Knife; the two most technologically advanced stereotactic radiosurgery systems in the world.
Through this new alliance, Hoag and Newport Diagnostic Center are jointly providing CyberKnife radiosurgery in Newport Beach at 1605 Avocado Avenue. Newport Diagnostic Center established the world’s first outpatient CyberKnife center and has been delivering CyberKnife treatments to qualified patients since 1996. For more information, or to determine if your patient is qualified for CyberKnife, please contact Hazem Chehabi, M.D., medical director of Newport Diagnostic Center or Amanda Schwer, M.D., Hoag-affiliated Radiation Oncologist, at 949/467-3061.